Home \ Mexidol®. Important differences from analogues

Mexidol®. Important differences from analogues

Problems of vascular pathology of the brain in the concept of cerebrometabolic health

Polymorbid patient with hypertension and cognitive impairment. Modern principles of treatment

Peculiarities of management of elderly patients with chronic cerebral ischemia

Methods for assessing the vegetative status in a patient with hypertension: from theory to practice

Pathogenetic analysis of cognitive impairment in comorbid patients as a basis for rational therapy

Brain in Focus of Arterial Hypertension: Minimizing Negative Prognosis

Anxiety in General Clinical Practice

Prevention and treatment of chronic heart failure. Possibilities of cytoprotective therapy

Complex approach in treatment of hypertension. Prevention of damage to target organs. Role and possibilities of cytoprotective therapy

Differentiated strategies of cerebroprotection in arterial hypertension: focus on proven efficacy

Time codes:
  • 00:00

    The expediency of using the original drug

  • 00:40

    Differences in the composition of the analogues of the drug Mexidol®, and the original drug

Schukin Ivan Aleksandrovich - Ph.D., Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics LF RNIMU named after N.I. Pirogov

Announcement:

Original drugs or analogues, what to choose? Why is it worth using the original Mexidol®, not generics? In this video, we will discuss the advantages of the original drug over analogues.

All video next video

Problems of vascular pathology of the brain in the concept of cerebrometabolic health

Polymorbid patient with hypertension and cognitive impairment. Modern principles of treatment

Peculiarities of management of elderly patients with chronic cerebral ischemia

Methods for assessing the vegetative status in a patient with hypertension: from theory to practice

Pathogenetic analysis of cognitive impairment in comorbid patients as a basis for rational therapy

Brain in Focus of Arterial Hypertension: Minimizing Negative Prognosis

Anxiety in General Clinical Practice

Prevention and treatment of chronic heart failure. Possibilities of cytoprotective therapy

Complex approach in treatment of hypertension. Prevention of damage to target organs. Role and possibilities of cytoprotective therapy

Differentiated strategies of cerebroprotection in arterial hypertension: focus on proven efficacy

Time codes:
  • 00:00

    The expediency of using the original drug

  • 00:40

    Differences in the composition of the analogues of the drug Mexidol®, and the original drug

Block of articles on this topic

Original and reproduced drugs: what do the clinician need to know?

Author:
A.V. Schulkin, A.A. Filimonova
FSBEI in the Ryazan State Medical University of the Ministry of Health of Russia, Ryazan, Russia

Read more
To the question of the evidence base of neuroprotective therapy: Focus on ethylmethylhydroxypyridine succinate

Authors:
A.I. Kochetkov, N.A. Shatalova, M.V. Klepikova, T.V. Filippova, O.D. Ostroumova
FSBEI DPO “Russian Medical Academy of Continuing Professional Education” of the Ministry of Health of Russia, Moscow

Read more
Reproduced drugs: Benefit ratio/risk

E.A. Ushkalova 1 , S.K. Zyryanov 1.2 , I.A. Gopienko 1
1 FGAOU in Russian University of Friendship of Peoples, Moscow;
2 GBUZ in Moscow "City Clinical Hospital No. 24 of the Department of Health of the city of Moscow", Moscow

Read more

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com